Onyx Biotec Reports Resignations of Managing Director and Whole Time Director
Onyx Biotec Limited, formerly known as Onxy Biotec Pvt. Ltd., announced key changes in its leadership following a Board meeting held on May 25, 2026. The Board of Directors noted the resignations of two senior executives, Mr. Sanjay Jain and Mr. Lakshya Jain, effective May 27, 2026.According to the company’s filings, Mr. Sanjay Jain resigned from his position as Managing Director and Director. His departure will also result in him ceasing to be a Member of the Stakeholders' Relationship Committee of the Company. Jain stated that his decision to step down was due to health considerations and the increasing demands associated with age, making it difficult for him to continue discharging the responsibilities of the role.
Concurrently, Mr. Lakshya Jain tendered his resignation from the role of Whole Time Director. Jain mentioned that his decision to exit the company was made to pursue opportunities that involve higher-risk exploration and experimentation ventures, stating this move aligns with his long-term professional goals and personal commitments.
Both executives provided confirmation that there are no material reasons for their resignations other than those detailed in their respective letters dated May 26, 2026.
The following table summarizes the details of the resignations:
| Executive Name | DIN | Position | Reason for Resignation | Effective Date |
|---|---|---|---|---|
| Sanjay Jain | 02214242 | Managing Director and Director | Health considerations and age demands | May 27, 2026 |
| Lakshya Jain | 09377707 | Whole Time Director | To pursue higher-risk exploration ventures | May 27, 2026 |
ONYX Stock Price Movement
Onyx Biotec Limited shares settled flat at ₹29.8 today, concluding the session with no change in valuation. The equity held steady, matching its previous closing price and indicating stability within the Pharmaceuticals & Biotechnology sector.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.